Announcements Trials
Browse Landscape Eligibility

Clinical Trials

14 trials
RecentStart dateEnrollment
Burns × Clear all

Phase

Phase NA 3Phase 4 2Phase 2 2Phase 1/2 2Phase 1 1

Status

Completed 7Unknown 2Not yet recruiting 2Withdrawn 1Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 10INDUSTRY 4

Study Type

Interventional 10Observational 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 3Dermatologic 2Classical hematology 2Sarcoma 1

Conditions

Breast Neoplasms 10998Neoplasms 8807Carcinoma, Non-Small-Cell Lung 5711Prostatic Neoplasms 5278Colorectal Neoplasms 4951Lung Neoplasms 4210Pancreatic Neoplasms 3003Multiple Myeloma 3001Neoplasm Metastasis 2954Leukemia, Myeloid, Acute 2927Carcinoma, Hepatocellular 2734Ovarian Neoplasms 2657Melanoma 2635Stomach Neoplasms 2567Lymphoma 2502Head and Neck Neoplasms 2162Recurrence 2132Precursor Cell Lymphoblastic Leukemia-Lymphoma 2069Leukemia 1992Brain Neoplasms 1971Colonic Neoplasms 1939Lymphoma, Non-Hodgkin 1894Rectal Neoplasms 1846Uterine Cervical Neoplasms 1806Glioblastoma 1699Leukemia, Lymphocytic, Chronic, B-Cell 1663Carcinoma, Renal Cell 1597Squamous Cell Carcinoma of Head and Neck 1550Lymphoma, Follicular 1526Esophageal Neoplasms 1516

Interventions

Fentanyl 2Sugars 1Fenofibrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements
NCT06303687 2025-11-24

VR-PAT and fNIRS to Identify CNS Biomarkers of Pain

Nationwide Children's Hospital

Phase NA Not yet recruiting
4 enrolled
LymphoidOther hematologic neoplasm

Pain, Procedural, Burns, Pain, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Acute Pain

NCT05549232 2025-07-23

Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital

Hemanext

Completed
22 enrolled 18 charts
Other hematologic neoplasm

Hypoxia, Burns, Hematologic Neoplasms

NCT05673551 2025-06-19

VR-PAT During Home Burn Dressings - Multisite

Nationwide Children's Hospital

Phase NA Enrolling by invitation
220 enrolled
LymphoidOther hematologic neoplasm

Pain, Procedural, Burns, Pain, Wounds and Injuries, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Acute Pain

NCT06591195 2024-09-19

DISTRACT

Radboud University Medical Center

Phase NA Not yet recruiting
126 enrolled
LymphoidOther hematologic neoplasm

Agnosia, Burns, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Acute Pain

NCT05148390 2024-02-21

GELFI

BSN Medical GmbH

Completed
36 enrolled

Surgical Wound, Burns, Pressure Ulcer, Leg Ulcer, Diabetic Foot, Lacerations

NCT06103409 2023-10-26

MSCs for the Treatment of Burn Wounds

Instituto Venezolano de Investigaciones Cientificas

Phase 1/2 Unknown
50 enrolled

Burns, Neoplasm Metastasis

NCT01436292 2022-11-17

Halburns

Centre hospitalier de l'Université de Montréal (CHUM)

Phase 4 Withdrawn

Burns, Neoplasm Metastasis, Hypoalbuminemia

NCT00540566 2022-10-20

Optical Biopsy of Human Skin in Conjunction With Laser Treatment

University of California, Irvine

Completed
113 enrolled
DermatologicSarcoma

Burns, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Dysplastic Nevus Syndrome, Hemangioma, Melanoma, Osteitis Deformans, Sarcoma, Kaposi, Carcinoma, Merkel Cell, Keratosis, Seborrheic, Histiocytoma, Benign Fibrous, Port-Wine Stain, Scleroderma, Diffuse

NCT02145130 2021-09-08

Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects

University of Zurich

Phase 1 Completed
12 enrolled
Dermatologic

Burns, Cicatrix, Necrosis, Skin Neoplasms, Soft Tissue Injuries

NCT01574131 2019-11-29

Acute and Long-Term Outcome Investigations of Fenofibrate on Severely Burned Patients

The University of Texas Medical Branch, Galveston

Phase 4 Terminated
3 enrolled

Burns, Insulin Resistance, Neoplasm Metastasis

NCT03113747 2017-04-26

ADSCs-BWs

A.A. Partners, LLC

Phase 1/2 Unknown
20 enrolled

Burns, Neoplasm Metastasis

NCT00236041 2014-05-09

Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 2 Completed
38 enrolled
Classical hematology

Agnosia, Anemia, Sickle Cell, Burns, Neoplasms, Breakthrough Pain

NCT00236093 2014-05-09

Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 2 Completed
Classical hematology

Anemia, Sickle Cell, Burns, Neoplasms, Pain

NCT01302223 2012-12-06

Keratinocyte Growth Factor and Cytokines in Burns.

Federal University of São Paulo

Completed
8 enrolled

Growth Factors, Combined Defect of, Cytokine Release Syndrome, Burns, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡